PI-LAB-2025-163

PT-141, Independent Lab Report

PT-141 5mg · Quantum Peptide Group

Verified

Independent testing verdict Pass

This product matched its label.

Identity confirmed and measured purity of 96.8% met the stated ≥98% claim. Content measured 98.3% of label.

Identity verified
Yes

Mass spectrometry confirmed the labelled compound

Measured purity
96.8%

Label claimed ≥98%

Content accuracy
98.2%

4.91mg measured against 5mg claimed

Test recency
Current cycle

Published 12 months ago

Specimen PI-LAB-2025-163 Tested by Redpoint Laboratories 12 samples tested from this company Purity & Testing score 98/100

Full laboratory evidence Findings table, methodology, chain of custody and the original report

Findings

Metric Label claim Measured Assessment
Purity (HPLC) ≥ 98% 96.8% Within analytical tolerance
Identity (MS) PT-141 Confirmed Matches label
Content 5 mg 4.91 mg Within 5% of label

Methodology & chain of custody

Reversed-phase HPLC purity analysis with UV detection at 214nm.

The sample was purchased anonymously through standard retail checkout and shipped to an unaffiliated address, then logged, photographed, and forwarded under chain-of-custody documentation to Redpoint Laboratories. See our full testing methodology.

Lot / batch
C6001-25
Purchased
Analysed
Published
Laboratory
Redpoint Laboratories
Test type
Content verification

Original laboratory report: PI-LAB-2025-163-report.pdf (document delivery arrives with the production storage backend)

More Tests, Quantum Peptide Group

BPC-157
Purity 97.1% Verified
Tirzepatide
Purity 97.8% Verified
Exenatide
Purity 98.5% Verified

More Tests, PT-141

PT-141 NextGen Peptides
Purity 98.5% Verified
PT-141 BioRegen Research
Purity 95.1% Verified
PT-141 Helix Research Supply
Purity 97.6% Discrepancy